Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_3
1
10%
Ph phase_2
6
60%
Ph phase_1
1
10%
Ph phase_4
1
10%

Phase Distribution

1

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
6(60.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(1)
Terminated(2)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Recruiting2
Withdrawn2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 26 (60.0%)
Phase 31 (10.0%)
Phase 41 (10.0%)
N/A1 (10.0%)

Trials by Status

not_yet_recruiting220%
recruiting220%
completed110%
unknown330%
withdrawn220%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_1

A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

NCT07178171
recruitingphase_2

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

NCT06714383
not_yet_recruitingnot_applicable

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

NCT05287308
withdrawnphase_2

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

NCT03342300
withdrawnphase_2

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

NCT02585479
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07178171Phase 1

A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Recruiting
NCT06714383Phase 2

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

Recruiting
NCT05287308Not Applicable

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Not Yet Recruiting
NCT03342300Phase 2

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Withdrawn
NCT02585479Phase 2

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

Withdrawn
NCT03892330Phase 4

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Not Yet Recruiting
NCT02740426Phase 2

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

Unknown
NCT02923557Phase 2

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

Unknown
NCT02613026Phase 3

Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

Completed
NCT00131053Phase 2

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10